Thus, as hs-cTnI levels are increasingly used in clinical routine instead of hs-cTnT levels, these data may help clinicians in the assessment of hs-cTnI levels in neonates with SMA. This evidence concerns the gene TNNI3 and proximal spinal muscular atrophy.